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Abstract
The aim of this study was to investigate the function of the Hippo pathway member Yes-associated protein (Yap, gene
name Yap1) in skeletal muscle fibres in vivo. Specifically we bred an inducible, skeletal muscle fibre-specific knock-in mouse
model (MCK-tTA-hYAP1 S127A) to test whether the over expression of constitutively active Yap (hYAP1 S127A) is sufficient
to drive muscle hypertrophy or stimulate changes in fibre type composition. Unexpectedly, after 5–7 weeks of constitutive
hYAP1 S127A over expression, mice suddenly and rapidly lost 20–25% body weight and suffered from gait impairments and
kyphosis. Skeletal muscles atrophied by 34–40% and the muscle fibre cross sectional area decreased by <40% when
compared to control mice. Histological analysis revealed evidence of skeletal muscle degeneration and regeneration,
necrotic fibres and a NADH-TR staining resembling centronuclear myopathy. In agreement with the histology, mRNA
expression of markers of regenerative myogenesis (embryonic myosin heavy chain, Myf5, myogenin, Pax7) and muscle
protein degradation (atrogin-1, MuRF1) were significantly elevated in muscles from transgenic mice versus control. No
significant changes in fibre type composition were detected using ATPase staining. The phenotype was largely reversible, as
a cessation of hYAP1 S127A expression rescued body and muscle weight, restored muscle morphology and prevented
further pathological progression. To conclude, high Yap activity in muscle fibres does not induce fibre hypertrophy nor fibre
type changes but instead results in a reversible atrophy and deterioration.
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Introduction
Skeletal muscle accounts for <38% of body mass in men, and
<31% in women [1]. Skeletal muscle comprises muscle fibres
which are terminally differentiated, multinucleated cells that can
be up to 20 cm long in human gracilis and sartorius muscles [2].
Muscle fibres are capable of hypertrophying in response to
overload and are able to regenerate following severe injury [3],
thanks mainly due to a resident population of stem cells which are
termed satellite cells [4–6]. Alterations in mature muscle fibre size
are determined predominately by a balance in protein synthesis
and degradation. Overload-induced muscle hypertrophy is mainly
regulated via mTORC1 signalling [7], stimulating protein
synthesis, whereas E3 ubiquitin ligases including Atrogin-1 and
MuRF-1 regulate protein degradation in catabolic settings. A fast-
to-slow fibre phenotype shift and increased mitochondrial bio-
genesis can also occur in response to stimuli such as endurance
exercise training and is mediated by calcineurin-NFAT, AMPK
and PGC-1a signalling [8–10]. Declines in muscle size and
function are key features of both aging and many disease states
including muscular dystrophy, cancer and diabetes, and are often
major contributors to disability and disease progression [11].
Although progress has been made in uncovering some of the
molecular signalling networks responsible for regulating skeletal
muscle, the identification of novel pathways that control muscle
function still represents a major objective in musculoskeletal
research, not least because of the therapeutic potential these
pathways may hold.
One such pathway could be the Hippo pathway which is a key
regulator of organ growth in mammals [12]. We recently found
that all major members of the Hippo pathway are expressed in
adult mouse skeletal muscle which suggests a role for Hippo
signalling in this tissue [13]. A key member of the Hippo pathway
is Yes-associated protein (Yap), a transcriptional co-factor ubiq-
uitously expressed in almost all cell types including skeletal muscle
[13–15]. Yap activity is negatively regulated by the Hippo
pathway via phosphorylation at multiple serine residues including
Ser127 by upstream kinase Lats1/2, which retains Yap in the
cytoplasm [12,16,17]. The protein kinase Mst1/2 interacts with
auxiliary proteins ww45 and mob1 to function genetically
upstream of Lats1/2, forming the core of the Hippo pathway
[12,16,17]. Yap can also be regulated independently of the
canonical Hippo pathway by proteins including a-catenin [18], b-
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catenin [19] and angiomotin [20,21]. Yap, its paralogue Taz
(transcriptional coactivator with PDZ-binding motif), and Vgll1-4
(vestigial-like, Vito, Tondu) all bind and co-activate Tead1-4
(TEA/ATTS domain/TEF/scalloped) transcription factors by
forming protein complexes via specific Tead-co-factor binding
domains [22–26]. Co-activated Teads then regulate the expression
of target genes by binding via their <70 amino acid TEA/ATTS
DNA binding domain to so-called MCAT elements (muscle C, A
and T; 59-CATTCC-39). A chip-on-chip analysis in MCF10A
mammary epithelial cells revealed that Yap and Tead1 occupy the
same promoters in <80% of cases [27], suggesting that Yap co-
activation of Tead isoforms is the major mechanism by which Yap
regulates gene expression.
The elements and function of the Hippo pathway were first
identified during tumour suppressor screens in drosophila melanogaster,
where knockout of the inhibitory components upstream of the Yap
homologue Yorkie resulted in overgrowth [28]. In mammals,
subsequent studies have confirmed that the Hippo pathway is a key
regulator of organ growth. Conditional liver-specific overexpression
of a constitutively active Yap (hYAP1 S127A) induces a <4 fold
increase in mouse liver size [29,30]. Expression of a constitutively
active Yap or deletion of inhibitory upstream Hippo pathway
member ww45/Sav, under cardiomyocyte specific promoters, has
been shown to induce an expansion of heart size in developing mice
[19,31,32]. Similar tissue-expanding functions ofYaphave also been
described for the skin and intestine [18,33–35]. Yap also acts as an
important controllerof stemcell identityand fate in several adult stem
and/or progenitor populations [36]. Indeed, we have recently
demonstrated that Yap promotes satellite cell and myoblast pro-
liferation but inhibits the differentiation of these cells [13,37].
To date, the function of Yap andHippo signalling in adult skeletal
muscle fibres remains unknown.Given the potent growth promoting
properties of Yap in other tissues we hypothesized that Yap could
induce muscle fibre hypertrophy in vivo. A previous study has
demonstrated Tead1, which Yap binds directly, is involved in up
regulatinga-actingeneexpression inhypertrophying chickenmuscle
[38]. Thus one possibility is that Yap may act via Tead1-4
transcription factors to regulate myofibrillar gene transcription
during hypertrophywhilst themTOR signalling, which is also active
after overload, up-regulates translation or protein synthesis. Howev-
er, more recently it was reported that muscle fibre-specific over
expression of Tead1 induces a fast-to-slow fibre type conversion in
mice [39]. Thus at this stage it is unclear how Tead1-4 transcription
factors, their co-activators and the Hippo pathway regulate the
phenotype of skeletal muscle fibres.
Here, we examined the effects of constitutive hYAP1 S127A
expression in adult skeletal muscle fibres (but not in satellite cells)
[40,41] using a mouse model in which a tetracycline responsive
hYAP1 S127A allele (TRE-hYAP1 S127A) is controlled by
a tetracycline transactivator (tTA) driven by the skeletal muscle-
specific muscle creatine kinase promoter (MCK-tTA). Unexpected-
ly,hYAP1S127Aoverexpressionresulted inmuscledegradation,and
atrophy,ratherthanmyofibrehypertrophyoranyfast-to-slowmuscle
fibre shift. Specifically, mice lost body weight and suffered from
kyphosis and decreased muscle mass after 5–7 weeks of transgene
expression.Histological analysis ofmuscle sections revealed centrally
located nuclei, necrotic fibres and nicotinamide adenine dinucleo-
tide-reductionase (NADH-RT) activity resembled that seen in
centronuclear myopathy. Interestingly, this degenerative and atro-
phicphenotypewas largely reversible, since removinghYAP1S127A
expression resulted in a regain of body and muscle weight and
restoration of a more normal muscle morphology.
Materials and Methods
Ethics Statement
All animal procedures were approved by the University of
Aberdeen Ethics Review Committee Board and performed under
a project license approved by the Home Office under the Animals
(Scientific Procedures) Act 1986 (PPL 60/3823).
Transgenic Mice and Genotyping
MCK-tTA mice were kindly donated by Dr. Kanneboyina
Nagaraju, The George Washington University Medical Centre,
USA [42]. Transgenic mice carrying the TRE-hYAP1 S127A
allele were created and kindly donated by Dr. Thijn R.
Brummelkamp, Whitehead Institute for Biochemical Research,
USA [34]. MCK-tTA mice were crossed with TRE-hYAP1
S127A mice to generate skeletal muscle specific hYAP1 S127A
knock-in mice.
Genotyping was performed on genomic DNA (gDNA) obtained
from mouse ear clip samples isolated using a DNeasy Blood and
Tissue Kit (Qiagen, USA) following the manufactures instructions.
Presence of MCK-tTA and TRE-hYAP1 S127A alleles was then
determined using a PCR-gel electrophoresis assays using primers
provided in the supporting information (Table S1).
Transgenic mice carrying both alleles (MCK-tTA-hYAP1
S127A) were used as experimental animals and mice carrying
a single TRE-hYAP1 S127A allele served as control mice. In this
‘tet-off’ system, transgene expression was suppressed by adminis-
tration of doxycycline (200 mg/ml) (Sigma) in drinking water
supplemented with 2% sucrose, until mice reached 6–10 weeks of
age. Activation of transgene expression was then achieved by
removal of doxycycline from drinking water.
Western Blotting
Following dissection, tissue samples were homogenised in RIPA
buffer (Tris 50 mM, NaCl 150 mM, SDS 0.1%, Na-Deoxycholate
0.5% and Triton-X 100 1% - supplemented with 50 mM of NaF,
0.5 mM of sodium orthovanadate, 1 mM of EDTA and a protease
inhibitor cocktail) at 4uC using a Precellys 24 bead mill
homogeniser (Bertin technologies, UK). Samples were centrifuga-
tion at 13,000 g for 10 minutes at 4uC and the resultant supernant
removed and assayed to determine protein concentration. 50–
90 mg of whole protein lysates were separated via SDS-PAGE
electrophoresis and transferred to nitrocellulose membranes.
Membranes were probed with the following primary antibodies
overnight at 4uC: rabbit anti-Yap (a gift from Dr Maris Sudol)
rabbit anti-Actin (Sigma), phospho-Akt/PKB Ser473 (Cell Signal-
ing #4060), total Akt/PKB (Cell Signaling #4685), phospho-p70
S6k Thr389 (Cell Signaling #9234), total p70 S6k (Cell Signaling
#9202), phospho-Smad2 Ser465/467 (Cell Signaling #3101),
total Smad2/3 (Cell Signaling #3102), phospho-Foxo3a Ser253(-
Cell Signaling #9466), Caspase 3 (Cell Signaling #9665). Primary
antibodies were then visualised using species-specific Alexa Fluor
488/555 labelled secondary antibodies (Invitrogen). Bands were
quantified using a LiCor Odyssey infrared imager.
RNA Isolation, cDNA Synthesis and RT-PCR
Following dissection, tissue samples were homogenised in 1 ml
TRIzol using a Precellys 24 bead mill homogeniser (Bertin
technologies, UK). RNA isolation, cDNA synthesis and end-point
PCR was performed as previously described [13] using primers for
hYAP1 andGapdh (primer sequences listed inTable S1).Quantitative
RT-PCR was performed on a Roche Lightcycler 480 (Roche, UK)
using Taqman assays. qRT-PCR primers and Taqman fluorogenic
probes were designed using the Roche Universal Probe Library and
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can be found in the supporting information (Table S1). All
quantification of mRNA was normalised to mouse Gapdh (Applied
Biosystems, USA) as an internal control using multiplexing assays.
Quantificationwas corrected for efficiencybyuse of a standard curve
created by the serial dilution of cDNA.
Skeletal Muscle Histology
Tibialis Anterior (TA) muscles were dissected from mice and
then immediately dipped into freezing isopentane (suspended in
liquid nitrogen) for 5–10 seconds and stored at 280uC. In
a 220uC cryostat-microtome (CM1850UV, Leica, U.K) tissues
were cut in a cross sectional orientation through the muscle mid
belly using a scalpel then embedded in optimum cutting
temperature (OCT) compound (Qiagen, USA) and mounted onto
the microtome. Cross sectional cryosections of 5 mm (immunohis-
tochemisty) and 10 mm (basic histology) thickness were then taken
from the mid-belly of muscle samples, mounted onto glass slides
(Thermo Fisher Scientific, USA) and stored at 220uC.
For haematoxylin and eosin (H+E) staining, frozen TA cryosec-
tions were thawed at room temperature, rinsed in distilled H2O,
incubated inhaematoxylin for3minutesand thenrinsed in tapwater.
Haematoxylin was then differentiated by dipping slides in 0.3% acid
alcohol (1%HCl in70%ETOH) three times then rinsing in tapwater
and placing in lithium carbonate for 30 seconds. Following further
washes in tap water, slides were finally stained with eosin Y (1%
solution) for 1 min. Sections were dehydrated by sequential dipping
in 70% and 100% ethanol and then Xylene, before being mounted
with coverslips using DPX mounting medium. Measurements of
muscle fibre cross sectional areaweremademanually from images of
TA sections (206magnification) following H+E staining using
ImageJ software (NIH – version 1.43, USA). Data was collected
from a minimum of 30 fibres per mouse selected at random as
previously described [43]. Regenerating muscle fibres were quanti-
fied following H+E staining and were expressed as a percentage of
total fibres with centrally located nuclei per section (1 section
quantified per mouse).
Necroticmuscle fibreswere distinguished based on their increased
permeability andaltered immunogenicproperties.Such fibres canbe
readily identified by incubating muscle sections with fluorescently
conjugated-IgG antibodies (secondary antibodies) as fibres un-
dergoing necrosis process a greater affinity to bind IgG’s [44–46].
IgG immunostaining was performed as previously described [46].
Briefly, frozen muscle cryosections (5 mm) were thawed and then
fixed in 4%PFA for 10minutes at room temperature in a humidified
chamber. Sections were permeabilized in PBS containing 0.2%
Triton X-100 for 10 minutes, before being incubated in blocking
solution (1% BSA in PBS) for 30 minutes at room temperature in
a humidified chamber. Sections were then incubated with an
Alexafluor 488-conjugated rabbit anti-mouse antibody (Invitrogen)
(1:200 in PBS) over night at 4uC. The following day, slides were
washed twice in PBS and thenmounted withVectashield containing
DAPI (Vector Laboratories, USA). Necrotic fibres (IgG+) were
quantifiedbymanual countingusing ImageJ software (NIH–version
1.43,USA) anddisplayed as the number of necrotic fibres per section
(1 section quantified per mouse).
For Nicotinamide adenine dinucleotide-tetrazolium reductase
(NADH-TR) staining, frozen muscle cryosections were thawed
and a drop of NADH-TR staining solution (0.68 g Tris base,
2.52 g Tris HCl, 0.10 g Nitro blue tetazolium, dissolved in 100 ml
distilled H2O –1 mg of NADH added to 1 ml staining solution
prior to staining) added to the slides. Samples were then incubated
with solution for 30–60 minutes at room temperature in
a humidified chamber. Samples were finally washed in tap water
before being dehydrated by sequential dipping in 70% and 100%
ethanol and then Xylene 1 and Xylene 2 and then mounted with
coverslips using DPX mounting medium.
For ATPase staining, TA muscle sections were pre-incubated at
pH 10.5 and then processed as previously described [47] in order
to distinguish fibre types. Percentages of muscle fibre types were
quantified manually by counting stained and unstained fibres from
at least three random fields (106magnification) taken from the
core and periphery of muscle sections in line with previously
described methods [43].
Serum Creatine Kinase Assay
Blood samples were collected from mice by cardiac puncture
and transferred to EDTA coated mini vacutainer tubes (BD
Biosciences, USA) and placed on ice. Following centrifugation for
10 minutes at 3500 rpm, blood plasma (clear layer) was aliquoted
into fresh tubes and stored at220uC. Plasma creatine kinase levels
were determined using a CK522 assay kit (Randox Laboratories,
UK) following the manufactures instructions. Creatine kinase
activity was measured using spectrophotometry at a light absor-
bance of 340 nm, applying the following formula: Creatine kinase
U/l = 41276D A 340 nm/min.
Results
Inducible, Skeletal Muscle Specific Expression of hYAP1
S127A in vivo
In order to investigate the function of Yap in adult skeletal
muscle fibres, we bred a transgenic knock-in mouse where we
could induce the over expression of constitutively active hYAP1
S127A in muscle fibres. For this we crossed mice possessing
a tetracycline responsive hYAP1 S127A allele (TRE-hYAP1
S127A) [34] with mice that express the tetracycline transactivator
(tTA) driven by the skeletal muscle-specific muscle creatine kinase
promoter (MCK-tTA) [42] (Figure 1B). In animals carrying both
alleles (MCK-tTA-hYAP1 S127A), this ‘Tet-Off’ system allows
skeletal muscle fibre-specific hYAP1 S127A expression to be
‘switched-off’ by doxycycline administration (in drinking water)
and ‘switched-on’ by doxycycline withdrawal (Figure 1A). To
validate this model, we first bred mice in the presence of
doxycycline (restricting in utero transgene expression) until offspring
were 6–8 weeks of age. Doxycycline was then removed from
MCK-tTA-hYAP1 S127A mice for 21 days, which led to an <8–
12 fold (densitometry, Figure S1) increase in Yap protein levels in
all skeletal muscles examined, compared to genotype controls
exposed to doxycycline, and single allele controls (Figure 1C).
Examination of hYAP1 mRNA in other tissues confirmed that the
expression of the transgene was restricted to the muscle linage,
especially skeletal muscle but also with a low expression in heart
(Figure 1D). No hYAP1 mRNA could be detected in mice carrying
a single TRE-hYAP1 S127A allele and were therefore employed
as control mice in this study (Figure 1D). Analysing tibialis anterior
(TA) muscles following doxycycline withdrawal revealed elevated
Yap protein levels from 3 days and peaking at 14–21 days post
doxycycline removal (Figure 1E).
Skeletal Muscle Specific Over-expression of hYAP1 S127A
Causes Weight Loss, Kyphosis and Muscle Wasting in
MCK-tTA-hYAP1 S127A Mice
To investigate the phenotype of constitutive hYAP1 S127A over
expression in skeletal muscle fibres, doxycycline was withdrawn
from the drinking water of 8–10 week old mice to induce
transgene expression. The mice were then monitored over 10
weeks for gross changes in phenotype. Induction of hYAP1 S127A
Yap and Skeletal Muscle Fibres
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over expression appeared to have no effect until 4–6 weeks after
doxycycline withdrawal, when mice rapidly lost 20–25% of their
body weight compared to controls (Figure 2A). Weight loss was
accompanied by an abnormal ‘dragging’ gait of the hind limbs as
a result of apparent weakness of the lower limbs (see video S1). An
obvious decrease in locomotor activity was also observed as well as
hutching, shivering and fur loss, which together indicate declining
health. MCK-tTA-hYAP1 S127A mice also developed marked
kyphosis (Figure 2B). Eventually transgenic mice reached a stage
where they had to be culled based on the experimental protocol
and advice by the veterinary doctor. This point was typically
reached between 5–7 weeks after doxycycline removal.
Tissue was obtained from mice 3 weeks after removal of
doxycycline, when no phenotype was obvious, and from between
5–7 weeks after doxycycline removal, at the point when the mice
displayed the most pronounced phenotype (as above). While
muscle weight was unaltered after 3 weeks of hYAP1 S127A
expression (Figure 2C), TA, gastrocnemius (Gas) and extensor
digitorum longus (EDL) muscle weights all significantly decreased
(by 33.5%, 39.5% and 33.4% respectfully after 5–7 weeks of
transgene expression when compared to control) (Figure 2C). Of
note, soleus weight was unchanged (Figure S2). Analysis of other
organs from transgenic mice revealed no significant alteration in
heart, spleen or kidney weight, although there was a general trend
towards a reduction in weight (Figure 2D).
Over Expression of hYAP1 S127A in Skeletal Muscle
Fibres Induces Degeneration, Necrosis, Atrophy and
Myopathy
To investigate the basis of the loss of muscle weight, histological
analysis of skeletal muscles from MCK-tTA-hYAP1 S127A mice
was performed. Haematoxylin-eosin (H+E) staining of TA cross
sections revealed myofibres with centrally located nuclei (<15%)
following 5–7 weeks of hYAP1 S127A expression. Central nuclei
are a sign of muscle regeneration (white arrows, Figure 3A,B and
quantified in Figure 3C). An accumulation of mononucleated cells
in the extracellular space between fibres was also prominent in
skeletal muscle from transgenic mice (black arrows, Figure 3A,B).
Although not specifically characterised, these cells are likely to be
immune cells that are recruited to sites of muscle damage in order
to clear necrotic debris. This is an immunological response typical
for regenerating muscle [48]. Immunostaining for embryonic
myosin heavy chain (eMyHC) provided further evidence for the
occurrence of ongoing muscle regeneration, with 5–7 weeks of
hYAP1 S127A expression inducing the appearance of eMyHC+
fibres in the affected parts of the muscle (Figure 3I, J).
In agreement with these observations, there was evidence of
significant muscle fibre necrosis in transgenic mice. Necrotic
muscle fibres were distinguished based on their increased
permeability and altered immunogenic properties and were
identified by incubating muscle cross sections with a fluorescently
conjugated antibody [44–46]. Muscles from hYAP1 S127A mice
displayed large numbers of necrotic fibres (IgG+, white arrows)
compared to control mice (Figure 3E,F,G). Five to seven weeks of
hYAP1 S127A transgene expression also induced a significant
Figure 1. Characterisation of MCK-tTA-hYAP1 S127A mouse model. A) Schematic outline of the inducible ‘Tet-Off’ transgenic system. B)
Genotyping of MCK-tTA and TRE-hYAP1 S127A alleles in single and double transgenic mice. C) Yap protein levels in skeletal muscles of transgenic
mice of indicated genotypes following 25 days with (+) or without (2) doxycycline (dox). Tibialis anterior (TA), gastrocnemius (Gas) and extensor
digitorum longus (EDL). D) Muscle specific expression of hYAP mRNA in MCK-tTA-hYAP1 S127A mice 25 days after doxycycline withdrawal. E) Time
course of Yap protein expression in tibialis anterior of MCK-tTA-hYAP1 S127A mice following doxycycline removal.
doi:10.1371/journal.pone.0059622.g001
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decrease in the cross sectional area of TA muscle fibres (40% mean
decrease, Figure 3D), showing that hYAP1 S127A induces muscle
fibre atrophy, in addition to degeneration.
Serum creatine kinase (CK) activity is commonly upregulated
after skeletal or cardiac muscle damage or in degenerative
myopathies [49]. Accordingly, MCK-hYAP1 S127A mice had
elevated levels of serum CK activity after 5–7 weeks of transgene
expression compared to control mice (Figure 3H).
hYAP1 S127A Over-expression in Skeletal Muscle Fibres
Generates a Phenoytpe with Characteristics of
Centronuclear Myopathy
Next, we assessed the metabolic properties of skeletal muscle
from control and transgenic mice using nicotinamide adenine
dinucleotide-reductionase (NADH-TR) staining as a marker of
mitochondrial enzyme activity. Unexpectedly, we found that fibres
from the MCK-tTA-hYAP1 S127A mice possessed a strong,
concentrated staining patterning in the cores of muscle fibres
(Figure 3K, L, quantified in Figure 3M). This adherent
mitochondrial distribution resembles the NADH-TR staining of
fibres from patients with centronuclear myopathy [50].
Gene Expression Profile of Muscle Over-expressing
hYAP1 S127A is Consistent with Degeneration and
Atrophy
To further characterise the skeletal muscle phenotype following
induction of hYAP1 S127A, we examined the mRNA expression
of several genes involved in regulating skeletal muscle regeneration
and atrophy. To this end, TA muscles were dissected from mice at
3 weeks and between 5–7 weeks after doxycycline withdrawal and
were compared with TA muscles from adult mdx mice (an animal
model of Duchenne muscular dystrophy with a dystrophin knock
out mutation) to provide a positive control for a degeneration/
regeneration gene expression profile.
No differences in gene expression were observed in TA muscles
at 3 weeks after doxycycline withdrawal, compared to control
mice. However, consistent with our histological observations, TA
muscles from MCK-tTA-hYAP1 S127A mice (5–7 weeks off
Figure 2. Weight loss, kyphosis and muscle wasting in MCK-tTA-hYAP1 S127A mice following transgene activation. A) Changes in
body weight of transgenic mice following doxycycline withdrawal. Dotted red lines indicate the weight of MCK-tTA-hYAP1 S127A mice after
doxycycline withdrawal. The black circles represent the mean of mice that remained on doxycycline. B) Gross phenotype of MCK-tTA-hYAP1 S127A
versus control mice. C) Skeletal muscle weights of control and transgenic mice following 3 weeks (n = 7) and 5–7 weeks (n = 15) of hYAP1 S127A
transgene expression. D) Organ weights taken from control and MCK-tTA-hYAP1 S127A mice (n = 8). All values present mean 6SEM and displayed as
percentage change from time point 0 (A) or control (D) or displayed as raw values (C). *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0059622.g002
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doxycycline) displayed an mRNA expression pattern typically
found in regenerating muscle with an up regulation of genes
associated with the activation, proliferation and differentiation of
satellite cells in response to degeneration/damage. Specifically,
Embryonic myosin heavy chain, whose expression is restricted to the
embryo and postnatal muscle regeneration, was greatly increased
(5122 mean-fold increase compared to control, Figure 4B).
Similarly, the myogenic regulatory factors Myf5 and Myogenin
and the satellite cell marker Pax7 were also significantly up
regulated in muscles from transgenic mice compared to controls
(7.9, 85.1 and 2.3 mean-fold increase respectively, Figure 4C, D,
E,). These alterations in gene expression were similar to those
Figure 3. Constitutive expression of Yap induces skeletal muscle degeneration, necrosis, atrophy and features of myopathy. hYAP1
S127A transgene expression was induced by doxycycline (dox) withdrawal for 3 weeks or 5–7 weeks before TA muscles were collected. A & B) H+E
staining of cross sections from control and MCK-tTA-hYAP1 S127A mice, revealing central nuclei (white arrows) and infiltrating cells (black arrows). C)
Quantification of fibres with centrally located nuclei (n = 18). D) Quantification of muscle fibre cross sectional area (n = 16). E & F) Necrotic fibre
staining of cross sections from control and MCK-tTA-hYAP1 S127A mice with fluorescently conjugated IgG. G) Quantification of necrotic fibres,
displayed as % of IgG+ myofibres per section (n = 10) H) Serum creatine kinase (CK) activity in control and MCK-tTA-hYAP1 S127A mice (n = 8). I & J)
Imunnofluorescent staining of embryonic myosin heavy chain (eMyHC) on cryosections from control and MCK-tTA-hYAP1 S127A mice. K, L & M)
Nicotinamide adenine dinucleotide-reductionase (NADH-TR) staining of TA muscle cross sections from control and MCK-tTA-hYAP1 S127A mice
(representative image from at least 10 transgenic mice, quantification based on n=9). All values present mean 6SEM. *P,0.05 ***P,0.001. Scale
Bars = 100 mm (H+E, NADH-RT), 100 mm (IgG+eMyHC).
doi:10.1371/journal.pone.0059622.g003
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measured in mdx muscles, providing robust evidence of a de-
generation-regeneration skeletal muscle phenotype. However, in
contrast to mdx muscles, Caspase-3 mRNA expression did not
increase (Figure 4F). Instead, the mRNA expression of the muscle
specific ubiquitin ligases Atrogin-1 and Muscle ring finger protein
(MuRF-1), which represent key regulators of muscle protein
breakdown in various pathological conditions, were significantly
increased in muscles from transgenic mice (5–7 weeks off
doxycycline) compared to control mice (Figure 4G, H). To test if
hYAP1 S127A expression is inducing fibrosis, we also examined
the mRNA expression of Connective tissue growth factor (Ctgf),
Fibronectin and Type-1 Collagen (Col1A1). Ctgf mRNA expression
was significantly increased in transgenic mice following 5–7 weeks
of doxycycline withdrawal compared to control mice (Figure S3)
and there was a trend for an increase in Col1A1 expression, but this
did not reach statistical significance (Figure S3). No significant
change in the expression Fibronectin was observed (Figure S3). In
agreement with these findings, Masson’s trichrome blue staining of
skeletal muscle sections from transgenic mice revealed evidence of
some limited fibrosis which was not quantified (black arrows,
Figure S3).
Since no differences in gene expression were observed after just
3 weeks following doxycycline withdrawal compared to control
mice, indicates that alterations in skeletal muscle phenotype
appear to take time to manifest following the induction of hYAP1
S127A expression. In addition to the observed reductions in
skeletal muscle weight, fibre cross sectional area and evidence of
fibre degeneration/necrosis, these biochemical data indicate that
hYAP1 S127A expression also correlates with the up regulation of
specific molecular pathways associated with muscle protein
breakdown and regeneration. However, analysis of selected
signalling proteins involved in skeletal muscle protein synthesis
and breakdown revealed no significant changes in the phosphor-
ylation status of Akt, p70S6K, Smad2/3 or Foxo3a at activity-
related phosphorylation sites (Figure S4), suggesting the Yap
appears to be operating via alternative pathways/mechanisms to
induce the observed phenotypes. Together these results show that
constitutive expression of Yap, unlike observations made in other
tissues, appears to drive degeneration and atrophy in skeletal
muscle.
Proportions of Muscle Fibre Types are Unchanged
Following Over Expression of hYAP1 S127A in vivo
Given that Yap is known to interact with Tead transcription
factors [27,37] which are involved in the regulation of muscle fibre
type, we examined if MCK-tTA-hYAP1 S127A mice displayed an
alteration in the proportion of Fast Type IIa/x/b fibres compared
to control mice. TA cross sections from transgenic mice 5–7 weeks
after doxycycline withdrawal were subjected to ATPase histo-
chemical staining. As the TA is comprised almost exclusively of
type IIa/x/b fibres, sections were pre-incubated at pH 10.5
followed by incubation with ATP and visualisation of the Pi
generated by the reaction, allowing distinction between Type IIa/
x (dark stained) and Type IIb (light/no stain) fibre types as
described in [47] (Figure 5A, B). Quantification from representa-
tive images taken from the deep and superficial portion of TA
muscle cross sections revealed no significant difference in Type IIb
versus IIa/IIx fibre type proportions between MCK-tTA-hYAP1
S127A and control mice (Figure 5C, D).
Muscle Atrophy can be Rescued by Reversal of hYAP1
S127A Over-expression in vivo
To test whether the skeletal muscle degeneration and wasting in
MCK-tTA-hYAP1 S127A transgenic mice is dependent on
Figure 4. Up regulation in genes associated with muscle regeneration and atrophy in MCK-tTA-hYAP1 S127A mice. TA muscles of
transgenic mice were harvested following doxycycline withdrawal at indicated time points and RNA processed for qRT-PCR analysis of A) hYAP1
mRNA, B) embryonic myosin heavy chain, C) Myf5 mRNA, D) Pax7 mRNA, E) myogenin mRNA, F) Caspase-3 mRNA, G) Atrogin-1 mRNA and H) MuRF-1
mRNA. Expression normalised to Gapdh. All values present mean 6SEM (n= 12) and are displayed as fold change relative to control. ***P,0.001,
**P,0.01, *P,0.05. Mdx Samples from a mouse model of Duchenne muscular dystrophy.
doi:10.1371/journal.pone.0059622.g004
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sustained expression of hYAP1 S127A, we conducted a rescue
experiment. For this, doxycycline was first withdrawn from the
drinking water of 8–10 week old mice, inducing weight loss as
previously observed (Figure 6A). Doxycycline was then re-
administered after 5 weeks to stop hYAP1 S127A over-expression.
Re-adminstration of doxycycline led to a gradual recovery of
mouse body weight (Figure 6A) and normalisation of Yap protein
levels (Figure 6B) after 5 weeks. Examination of skeletal muscles 5
weeks after re-administration of doxycycline revealed an almost
complete restoration of muscle weight (Figure 6C) and partial
recovery of histology (Figure 6D,E,F,G). NADH-RT staining
resumed an appearance comparable to control mice (Figure 6D,E).
Muscle fibres with centrally located nuclei were still present (<5%
of total fibres), (white arrows Figure 6D, quantified Figure 6E).
These data clearly indicate that inactivation of hYAP1 S127A
expression is sufficient to prevent further pathological progression
as well as rescue aspects of the muscle phenotype that was induced
by hYAP1 S127A over expression.
Discussion
Previous observations with YAP in other tissues and organs
suggested that constitutive expression in muscle may induce
myofibre hypertrophy or alter muscle fibre type composition.
Using an inducible, tissue specific hYAP1 S127A knock-in mouse
however, we have found that instead, constitutive expression of
hYAP1 S127A in adult muscle fibres caused muscle atrophy and
Figure 5. No alteration in muscle fibre type proportions following over expression of hYAP1 S127A in vivo. A+B) hYAP1 S127A
transgene expression was induced by doxycycline (dox) withdrawal for 5–7 weeks before TA muscles were collected, sectioned and subjected to
ATPase histochemical staining following a pH10.5 pre-incubation. C+D) Quantification of the proportion of Type IIa/x (dark) and Type IIb (light/no
stain) fibres in the deep and superficial portions of muscle sections. Values present mean 6SEM (n= 10) and displayed as percentage of total fibres
per image from 3 representative images per mouse. Scale Bar = 200 mm.
doi:10.1371/journal.pone.0059622.g005
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degeneration. Importantly, these changes could be largely reversed
by then reversing the hYAP1 S127A over-expression.
Five to seven weeks of hYAP1 S127A expression induced
a significant decrease in TA, GAS and EDL weights, but no
change in soleus weight,. The reason for this muscle group
specificity is unclear, although not uncommon in muscle wasting
phenotypes. Selective sparing of the soleus has been observed in
both human and rodent models of cachexia and there is evidence
that the high proportion of type I fibres may be protective against
catabolic stimuli [51,52]. Analysis of skeletal muscle fibre cross
sectional area from induced hYAP1 S127A knock-in transgenic
mice revealed muscle weight loss due to muscle fibre atrophy. In
agreement with this observation, mRNA expression of the muscle
specific E-3 ubiquitin ligases, MuRF1 and Atrogin-1 were
significantly up-regulated following 5–7 weeks of hYAP1 S127A
expression, but not after 3 weeks of doxycycline withdrawal nor in
mdx mice. MuRF-1 and Atrogin-1 are up-regulated during muscle
atrophy and target muscle-specific proteins for degradation by the
proteasome [53]. There are many similarities between MCK-tTA-
hYAP1 S127A mice and MuRF-1 knock-in mice [54]. Although
E-3 ubiquitin ligases have been shown to negatively regulate
various members of the Hippo pathway [55], including Yap [56],
whether Yap is capable of directly driving MuRF-1 or Atrogin-1
expression, or is involved in their protein regulation, remains
unknown. There is currently no evidence linking Yap to the up
regulation of ubiquitin or proteasome pathways. Recent evidence
in breast cancer cells has shown Yap is instead capable of
protecting specific proteins against E-3 ubiquitin ligase mediated
polyubiquitination [57]. MuRF-1 and Atrogin-1 mRNA levels
were not up-regulated after 3 weeks of hYAP1 S127A expression,
suggesting that Yap is unlikely to be targeting these genes directly
in adult skeletal muscle fibres.
Figure 6. Re-administration of doxycycline partially rescues muscle phenotype induced by hYAP1 S127A expression. hYAP1 S127A
transgene expression was induced for 5 weeks and then stopped by the re-administration of doxycycline (dox) for 5 weeks (hYAP1 S127A rescued). A)
Weekly changes in mouse body weight throughout trial B) Western blot of Yap protein expression from control and hYAP1 S127A rescued mice. C)
Quantification of TA, GAS, EDL muscle weights from control and hYAP1 S127A rescued mice. D+E) Representative images of NADH-TR stained TA
cross sections of control and hYAP1 S127A rescued mice. F+G) Representative images of H+E staining from TA cross sections of control and hYAP1
S127A rescued mice. E) Quantification of centrally located nuclei. F) Western blot of Yap protein expression from control and hYAP1 S127A rescued
mice. Values present mean6SEM (n = 6). Weights are displayed as percentage change from control. Central nuclei are displayed as the percentage of
muscle fibres that had central nuclei. Scale bars = 100 mm.
doi:10.1371/journal.pone.0059622.g006
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In addition to muscle atrophy, hYAP1 S127A over-expression
also led to muscle degeneration. Histological analysis of skeletal
muscle sections from transgenic mice revealed evidence of
centrally-located nuclei and the appearance of embryonic myosin
heavy chain-expressing fibres: hallmarks of muscle regeneration.
In support of these observations, molecular markers of re-
generative myogenesis including embryonic myosin heavy chain, Pax7,
Myf5 and Myogenin were up-regulated in a genetic signature
indicative of satellite cell activation and differentiation during
muscle repair [6], and consistent with the gene expression profile
of mdx muscle. We have recently shown that Yap influences the
expression of the myogenic regulatory factors Myf5 and Myogenin
as well as Pax7 in myoblasts [13,37]. Importantly, the MCK
promoter is active in differentiated muscle fibres [40,41], but not
in satellite cells or other myogenic stem cells or progenitors until
they undergo myogenic differentation. No change in Pax7,Myf5 or
Myogenin mRNA was observed 3 weeks following hYAP1 S127A
induction, indicating that such gene expression changes are likely
the result of muscle stem cell-mediated regeneration occurring
within the muscle tissue of transgenic mice, rather that hYAP1
S127A directly targeting these genes in muscle fibres.
Previous studies in mouse and Drosophila melanogaster have
highlighted Yap and Yorkie (Drosophila melanogaster homologue of
Yap) as potent promoters of cell growth, survival and resistance to
death in almost all cell and tissue types investigated. Yet, in adult
skeletal muscle fibres, constitutive expression of Yap drives
atrophy, degeneration and necrosis. These data highlight impor-
tant tissue specific differences in the function of Yap and suggest
that Yap does not always represent a universal growth regulator as
has been suggested [30]. Interestingly, this study provides one of
the first investigations into the function of Yap in mammalian,
post-mitotic cells in vivo. Previous studies have focused on cell
populations within the liver (oval cells), intestine (crypt progeni-
tors), skin (epidermal progenitors) and embryonic heart (cardio-
myocytes) that can all still proliferate [18,30–35]. In these cell
types Yap is able to induce growth by driving cell cycle and
increasing cell number (hyperplasia). However, while mouse
muscle initially grows postnatally by both hypertrophy (increase
in myofibre size) and an increase in myonuclear content from
satellite cells, after 3 weeks of age any expansion in muscle size
occurs almost exclusively through hypertrophy [58]. This implies
that Yap is unable to promote growth without cell division, in the
same manner as it does in other tissues. Indeed, a recent study
investigating Yap gain of function in foetal mouse hearts provided
robust evidence for the growth promoting function of Yap coming
entirely from enhanced proliferation, rather than a hypertrophy of
cardiomyocytes [31]. These cell type specific differences in
proliferative capacity may go some way in explaining the distinct
effect that Yap over expression has in skeletal muscle when
compared to other tissues.
No significant change in the mRNA expression of Col1A1 and
Fibronectin was observed in skeletal muscles of transgenic mice,
suggesting 5–7 weeks of hYAP1 S127A over expression do not
cause fibrosis. However, hYAP1 S127A did induce a significant
increase in Ctgf mRNA. The Ctgf gene has three MCAT elements
in its proximal promoter (MCAT) and generally responds to
hYAP1 S127A over expression [27]. A recent study has shown
over expression of Ctgf in skeletal muscle in vivo induces a similar
phenotype as that seen in MCK-tTA-hYAP1 S127A mice [59].
Morales et al., observed adenoviral delivery of Ctgf in mouse TA
muscle induced myofibre necrosis, damage and degeneration
within days of transgene induction [59]. Assessments of muscle
function also showed over expression of Ctgf produced a significant
reduction in isometric contraction force. Although Ctgf is an
established transcriptional target of Yap [27] and its expression is
markedly increased in skeletal muscles of MCK-tTA-hYAP1
S127A mice, it remains to be seen if this may represent a possible
mechanism of action responsible for the muscle phenotypes
observed.
Histochemical ATPase staining revealed no significant changes
in the percentage of Type IIa/x and Type IIb fibres in TA muscle,
suggesting that hYAP1 S127A transgene expression does not
induce a shift of fibre type. In mouse, skeletal muscle specific over
expression of Tead1, a known DNA binding partner of Yap, has
been shown to induce an increase in the abundance of Type IIa
myosin heavy chain protein and decrease in Type IIb myosin
heavy chain isoform expression, indicative of a shift to a ‘slower’
contractile phenotype [39]. These results are not consistent with
the phenotype of MCK-tTA-hYAP1 S127A mice following
transgene activation allowing speculation that Yap is unlikely to
be regulating the same target genes as the Tead1 knock-in mouse
model [39] and is therefore operating through an alternative
mechanism. Further analysis is required to confirm this.
An unexpected histological feature of skeletal muscles from
MCK-tTA-hYAP1 S127A mice was the appearance of groups of
myofibres with intense, centrally-located NADH-TR staining.
Interestingly, similar NADH-TR staining patterns are observed in
some myopathies [50,60–62]. For example, centronuclear myo-
pathies, a group of rare human congential myopathies, are defined
pathologically by the presence of centrally-located nuclei [62], and
share comparable metabolic staining features as when hYAP1
S127A is over-expressed. Skeletal muscle characteristics of centro-
nuclear myopathy include increased oxidative enzyme activity and
glycogen staining in the central areas of muscle fibres [50].
Sections taken from patient muscle biopsies stained for oxidative
enzyme activity (NADH-TR/NBT) show fibres with a pale halo at
the periphery of the fibre, with central areas of fibres occupied by
aggregates of mitochondria and glycogen particles [50,60]. Such
metabolic staining patterns appear to closely match those observed
in groups of muscle fibres from MCK-tTA-hYAP1 S127A mice
following transgene activation. In humans, the genetic causes of
centronuclear myopathies are heterogeneous. Genetic linkage
studies have found X-linked recessive centronuclear myopathy is
caused by mutations in the gene MTM1 (encodes protein
Myotubularin) [63], whereas autosomal dominant and recessive
forms are caused by mutations in DNM2 (encodes protein
Dynamin 2) [64] and BIN1 (encodes protein Amphiphysin 2)
[65] genes respectively. There is currently little direct or indirect
evidence linking Yap with centronuclear myopathy or any of the
genes associated with the disease, with no reports demonstrating
disruption of Hippo signalling or Yap in any myopathies to date.
Whether the patterns of metabolic staining in skeletal muscles of
MCK-tTA-hYAP1 S127A mice are merely analogous to CNM or
provide evidence for an involvement of Yap in pathology of
centronuclear myopathy is unknown.
In summary, we have shown that unlike other tissues, including
liver, skin and heart, constitutive expression of Yap in skeletal
muscle fails to induce growth. Instead, we found that hYAP1
S127A expression in adult muscle fibres induces muscle atrophy,
degeneration and features of myopathy, providing important
insight into the tissue specific phenotypes induced by Yap over-
expression. This is reversible though, since extinguishing hYAP1
S127A expression leads to a rapid restoration of muscle weight and
morphology. Based on our findings, sustained expression of Yap is
unlikely to provide a viable target for future therapies in the
treatment of muscle wasting conditions.
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Supporting Information
Figure S1 Quantification of Yap protein levels from
MCK-tTA-hYAP1 S127A mice following doxycycline
withdrawal. Densitometry of Western Blots in Figure 1C,
showing Yap protein levels relative to actin in skeletal muscles of
transgenic mice of indicated genotypes following 25 days with (+)
or without (2) doxycycline (dox). All values present mean 6SD
(n= 3) and are displayed as fold change relative to control (mice
carrying single hYAP1 S127A allele) ***P,0.001.
(TIF)
Figure S2 Weights of soleus muscles from MCK-tTA-
hYAP1 S127A and control mice. hYAP1 S127A transgene
expression was induced by doxycycline (dox) withdrawal for 5–7
weeks and then soleus muscles were collected and weighed. All
values present mean 6SEM and displayed raw values (n = 15).
(TIF)
Figure S3 No significant fibrotic tissue accumulation in
skeletal muscles of MCK-tTA-hYAP1 S127A mice. TA
muscles of transgenic mice were harvested 5–7 weeks following
doxycycline (dox) withdrawal. RNA was isolated and processed for
qRT-PCR analysis of A) Contective tissue growth factor (Ctgf) mRNA,
B) Fibronectin mRNA C) Type-1 Collagen (Col1A1) mRNA. D+E)
Masson’s trichrome blue staining of TA sections from control and
MCK-tTA-hYAP1 S127A mice. Black arrows highlight small
areas of fibrotic tissue (blue staining). mRNA expression normal-
ised to Gapdh mRNA. Values present mean 6SEM and displayed
as fold change relative to control mice (n = 8). ***P,0.001.
(TIF)
Figure S4 Cell signalling in skeletal muscle of MCK-
tTA-hYAP1 S127A. TA muscles of transgenic mice were
harvested 3 weeks or 5–7 weeks following doxycycline withdrawal.
Protein was isolated from muscle samples and processed for
Western blotting. Membranes were probed with indicated
antibodies. Densitometry was performed and normalised to
indicated total proteins for A) pAkt, B) p-p70S6K, C) pSmad, D)
pFoxo3 and E) caspase. Values present mean 6SEM and
displayed as fold change relative to control mice (n = 4–8).
(TIF)
Table S1 Primer details. PCR primers for genotyping, end-
point PCR primers for hYAP and Gapdh mRNA and qRT-PCR
primers and probes (Roche Universal Probe Library).
(DOCX)
Video S1 Videos of MCK-tTA-hYAP1 S127A (hYAP1
S127A) and control mice following 5–7 weeks of doxycy-
cline withdrawal. Videos highlight decreased locomotion,
hutching and gait impairment seen in transgenic animals.
(WMV)
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